Research Analysts Set Expectations for ACHC FY2024 Earnings

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Analysts at KeyCorp issued their FY2024 earnings estimates for shares of Acadia Healthcare in a research note issued on Monday, January 6th. KeyCorp analyst M. Gillmor forecasts that the company will post earnings of $3.39 per share for the year. KeyCorp currently has a “Overweight” rating and a $70.00 price target on the stock. The consensus estimate for Acadia Healthcare’s current full-year earnings is $3.38 per share. KeyCorp also issued estimates for Acadia Healthcare’s Q4 2024 earnings at $0.73 EPS, Q1 2025 earnings at $0.66 EPS, Q4 2025 earnings at $0.77 EPS, FY2025 earnings at $3.20 EPS and FY2026 earnings at $3.98 EPS.

Several other research firms also recently weighed in on ACHC. Royal Bank of Canada dropped their price target on Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating on the stock in a research note on Monday, November 18th. TD Cowen cut their price target on shares of Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating on the stock in a report on Tuesday. Cantor Fitzgerald restated a “neutral” rating and set a $52.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, December 10th. Barclays reduced their target price on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a report on Friday, November 22nd. Finally, StockNews.com lowered shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Monday. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $70.22.

Acadia Healthcare Price Performance

Shares of ACHC opened at $45.12 on Thursday. The firm has a market capitalization of $4.19 billion, a PE ratio of 14.79, a price-to-earnings-growth ratio of 1.77 and a beta of 1.29. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. The company’s fifty day moving average price is $40.43 and its 200-day moving average price is $58.28. Acadia Healthcare has a 1-year low of $36.50 and a 1-year high of $87.77.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.90 by $0.01. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The firm had revenue of $815.60 million during the quarter, compared to analyst estimates of $819.42 million. During the same quarter in the prior year, the business posted $0.91 EPS. The business’s revenue for the quarter was up 8.7% compared to the same quarter last year.

Institutional Trading of Acadia Healthcare

Several institutional investors have recently bought and sold shares of the business. Wellington Management Group LLP raised its stake in shares of Acadia Healthcare by 12.2% during the 3rd quarter. Wellington Management Group LLP now owns 11,658,253 shares of the company’s stock worth $739,250,000 after buying an additional 1,266,384 shares during the period. William Blair Investment Management LLC lifted its holdings in Acadia Healthcare by 20.7% during the second quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company’s stock valued at $237,434,000 after purchasing an additional 604,070 shares in the last quarter. JPMorgan Chase & Co. grew its position in shares of Acadia Healthcare by 17.0% in the third quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock valued at $198,258,000 after purchasing an additional 454,044 shares during the period. State Street Corp increased its stake in shares of Acadia Healthcare by 3.5% during the third quarter. State Street Corp now owns 2,819,911 shares of the company’s stock worth $178,811,000 after purchasing an additional 95,613 shares in the last quarter. Finally, Point72 Asset Management L.P. raised its position in shares of Acadia Healthcare by 0.5% during the 3rd quarter. Point72 Asset Management L.P. now owns 2,282,810 shares of the company’s stock worth $144,753,000 after purchasing an additional 12,470 shares during the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.